A detailed history of Kerber Rose Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Kerber Rose Wealth Management, LLC holds 3,055 shares of ABBV stock, worth $540,582. This represents 0.38% of its overall portfolio holdings.

Number of Shares
3,055
Holding current value
$540,582
% of portfolio
0.38%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

BUY
$137.62 - $174.96 $420,429 - $534,502
3,055 New
3,055 $468,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Kerber Rose Wealth Management, LLC Portfolio

Follow Kerber Rose Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kerber Rose Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kerber Rose Wealth Management, LLC with notifications on news.